Zydus Lifesciences Planning to Acquire LiqMeds Group for Rs 689 Crore
Indian Pharmaceutical major Zydus Lifesciences, on 31 October, announced that its board had approved the acquisition of LiqMeds for Rs 689 crore. The company is...
Download Unicorn Signals App
Powered By EquityPandit
